Comparing Universal Health Services (UHS) & Fresenius Medical Care AG & Co. (FMS)

Universal Health Services (NYSE: UHS) and Fresenius Medical Care AG & Co. (NYSE:FMS) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and target prices for Universal Health Services and Fresenius Medical Care AG & Co., as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Universal Health Services 0 3 11 0 2.79
Fresenius Medical Care AG & Co. 0 3 4 0 2.57

Universal Health Services presently has a consensus target price of $130.00, suggesting a potential upside of 10.09%. Fresenius Medical Care AG & Co. has a consensus target price of $53.00, suggesting a potential downside of 4.93%. Given Universal Health Services’ stronger consensus rating and higher possible upside, analysts clearly believe Universal Health Services is more favorable than Fresenius Medical Care AG & Co..

Volatility & Risk

Universal Health Services has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, Fresenius Medical Care AG & Co. has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500.

Earnings and Valuation

This table compares Universal Health Services and Fresenius Medical Care AG & Co.’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Universal Health Services $9.77 billion 1.15 $702.40 million $7.27 16.24
Fresenius Medical Care AG & Co. $17.91 billion 1.91 $1.24 billion $2.23 25.00

Fresenius Medical Care AG & Co. has higher revenue and earnings than Universal Health Services. Universal Health Services is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co., indicating that it is currently the more affordable of the two stocks.

Dividends

Universal Health Services pays an annual dividend of $0.40 per share and has a dividend yield of 0.3%. Fresenius Medical Care AG & Co. pays an annual dividend of $0.37 per share and has a dividend yield of 0.7%. Universal Health Services pays out 5.5% of its earnings in the form of a dividend. Fresenius Medical Care AG & Co. pays out 16.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Fresenius Medical Care AG & Co. has increased its dividend for 2 consecutive years. Fresenius Medical Care AG & Co. is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Profitability

This table compares Universal Health Services and Fresenius Medical Care AG & Co.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Universal Health Services 6.90% 15.13% 6.92%
Fresenius Medical Care AG & Co. 7.04% 11.51% 5.00%

Insider and Institutional Ownership

86.1% of Universal Health Services shares are held by institutional investors. Comparatively, 3.0% of Fresenius Medical Care AG & Co. shares are held by institutional investors. 13.2% of Universal Health Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Universal Health Services beats Fresenius Medical Care AG & Co. on 10 of the 17 factors compared between the two stocks.

About Universal Health Services

Universal Health Services, Inc. is a holding company. The Company’s principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company’s segments include Acute Care Hospital Services, Behavioral Health Services and Other. As of February 28, 2017, the Company owned and/or operated 319 inpatient facilities, and 33 outpatient and other facilities, located in 37 states, Washington, District of Columbia, the United Kingdom, Puerto Rico and the United States Virgin Islands. The Company’s hospitals provide a range of services, such as oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. As of February 28, 2017, its acute care facilities located in the United States included 26 inpatient acute care hospitals; four free-standing emergency departments, and four outpatient surgery/cancer care centers and one surgical hospital.

About Fresenius Medical Care AG & Co.

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment. The Company develops and manufactures a range of dialysis machines, systems and disposable products. As of December 31, 2016, the Company sold its products to customers in more than 120 countries and also used in its internal healthcare service operations. The Company’s Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services, ambulatory surgery center services and urgent care services.

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply